Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors

Oncology

Volumn 68, Issue 4-6, 2005, Pages 414-421

  Barzon, Luisa ^a   Pacenti, Monia ^a   Masi, Giulia ^a   Stefani, Anna Lisa ^a   Fincati, Karina ^a   Palù, Giorgio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Adrenal gland neoplasms; Adrenocortical carcinoma; Cushing's syndrome; Ghrelin; Growth hormone secretagogue receptors; Real time polymerase chain reaction

Indexed keywords

GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1A; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1B; MESSENGER RNA; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX FUNCTION; ADULT; ARTICLE; BENIGN TUMOR; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RNA TRANSCRIPTION; TUMOR CELL;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH HORMONE; HUMANS; PEPTIDE HORMONES; PEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 23844534770     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086983     Document Type: Article

References (35)

1. Barzon L, Sonino N, Fallo F, Palù G, Boscaro M: Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003;149:273-285.
2. Luton JP, Gerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, Laudat MH, Louvel A, Chapuis Y, Blondeau P, Bonnin A, Bricaire H: Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195-1201.
3. Barzon L, Fallo F, Sonino N, Daniele O, Boscaro M: Adrenocortical carcinoma: Experience in 45 patients. Oncology 1997;54:490-496.
4. Koch CA, Pacak K, Chrousos GP: The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 2002;87:5367-5384.
5. Mesiano S, Mellon SH, Jaffe RB: Mitogenic action, regulation and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 1993;76:968-976.
6. Fottner C, Engelhardt D, Weber MM: Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins. J Endocrinol 1998;158:409-417.
7. Weber MM, Fottner C, Wolf E: The role of the insulin-like growth factor system in adrenocortical tumorigenesis. Eur J Clin Invest 2000; 30(suppl 3):69-75.
8. Mercado M, DaVila N, McLeod JF, Baumann G: Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues. J Clin Endocrinol Metab 1994;78:731-735.
9. Lin CJ, Mendonca BB, Lucon AM, Guazzelli IC, Nicolau W, Villares SM: Growth hormone receptor messenger ribonucleic acid in normal and pathologic human adrenocortical tissues - An analysis by quantitative polymerase chain reaction technique. J Clin Endocrinol Metab 1997;82:2671-2676.
10. Van der Lely AJ, Tschop M, Heiman ML, Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004;25:426-457.
11. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
12. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988-2991.
13. Tortorella C, Macchi C, Spinazzi R, Malendowicz LK, Trejter M, Nussdorfer GG: Ghrelin, an endogenous ligand for the growth hormone-secretagogue receptor, is expressed in the human adrenal cortex. Int J Mol Med 2003;12:213-217.
14. Carraro G, Albertin G, Abudukerimu A, Aragona F, Nussdorfer GG: Growth hormone secretagogue receptor subtypes 1a and 1b are expressed in the human adrenal cortex. Int J Mol Med 2004;13:295-298.
15. Barreiro ML, Pinilla L, Aguilar E, Tena-Sempere M: Expression and homologous regulation of GH secretagogue receptor mRNA in rat adrenal gland. Eur J Endocrinol 2002;147:677-688.
16. Andreis PG, Malendowicz LK, Trejter M, Neri G, Spinazzi R, Rossi GP, Nussdorfer GG: Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Lett 2003;536:173-179.
17. Weiss LM: Comparative histologic study of 43 metastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-169.
18. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB: The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:881-887.
19. Barlier A, Zamora AJ, Grino M, Gunz G, Pellegrini-Bouiller I, Morange-Ramos I, Figarella-Branger D, Dufour H, Jaquet P, Enjalbert A: Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: Polymerase chain reaction, triple in-situ hybridization and cell culture studies. J Neuroendocrinol 1999;11:491-502.
20. Kim K, Arai K, Sanno N, Osamura RY, Teramoto A, Shibasaki T: Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Clin Endocrinol (Oxf) 2001;54:759-768.
21. Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G, Ghigo E: Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab 2001;86:5052-5059.
22. Arnaldi G, Mancini T, Kola B, Appolloni G, Freddi S, Concettoni C, Bearzi I, Masini A, Boscaro M, Mantero F: Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. J Clin Endocrinol Metab 2003;88:5834-5840.
23. Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, Muccioli G, Ghigo E, Papotti M: Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002;87:1300-1308.
24. Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E, Muccioli G: Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 2001;86:1738-1745.
25. Cassoni P, Papotti M, Catapano F, Ghe C, Deghenghi R, Ghigo E, Muccioli G: Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. J Endocrinol 2000;165:139-146.
26. Volante M, Allia E, Fulcheri E, Cassoni P, Ghigo E, Muccioli G, Papotti M: Ghrelin in fetal thyroid and follicular tumors and cell lines: Expression and effects on tumor growth. Am J Pathol 2003;162:645-654.
27. Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, Pinilla L, Paniagua R, Nistal M, Casanueva FF, Aguilar E, Dieguez C, Tena-Sempere M: Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 2004;89:400-409.
28. Jeffery PL, Herington AC, Chopin LK: Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 2002;172:R7-R11.
29. Duxbury MS, Waseem T, Ito H, Robinson MK, Zinner MJ, Ashley SW, Whang EE: Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun 2003;309:464-468.
30. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kangawa K, Chihara K: Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 2002;277:5667-7564.
31. Tamura H, Kamegai J, Sugihara H, Kineman RD, Frohman LA, Wakabayashi I: Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J Neuroendocrinol 2000;12:481-485.
32. Petersenn S, Rasch AC, Penshorn M, Beil FU, Schulte HM: Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology 2001;142:2649-2659.
33. Camina JP, Carreira MC, El Messari S, Llorens-Cortes C, Smith RG, Casanueva FF: Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 2004;145:930-940.
34. Bohm SK, Grady EF, Bunnett NW: Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J 1997;322:1-18.
35. Belloni AS, Macchi C, Rebuffat P, Conconi MT, Malendowicz LK, Parnigotto PP, Nussdorfer GG: Effect of ghrelin on the apoptotic deletion rate of different types of cells cultured in vitro. Int J Mol Med 2004;14:165-167.